Cholecystokinin octapeptide inhibits the inﬂammatory response and improves neurological outcome in a porcine model of cardiopulmonary resuscitation

Ye,Sen; Shi,Kejia; Xu,Jiefeng; Wang,Moli; Li,Chun‑Jian

doi:10.3892/etm.2017.5680

Cholecystokinin octapeptide inhibits the inﬂammatory response and improves neurological outcome in a porcine model of cardiopulmonary resuscitation

Authors:
- Sen Ye
- Kejia Shi
- Jiefeng Xu
- Moli Wang
- Chun‑Jian Li
View Affiliations

Affiliations: Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China, Department of Emergency, People's Hospital of Yuyao, Yuyao, Zhejiang 315400, P.R. China
Published online on: December 27, 2017 https://doi.org/10.3892/etm.2017.5680
Pages: 2583-2588

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Previous studies have demonstrated that cholecystokinin octapeptide (CCK8) induces hypothermia and inhibits the systemic inflammatory response in septic shock in rat and murine models. The present study aimed to ascertain whether CCK8 induced hypothermia and improved the neurological outcomes in a porcine model of cardiopulmonary resuscitation (CPR). Ventricular fibrillation was induced and left untreated for 10 min in 12 male Bama miniature pigs. Defibrillation was attempted after 5 min of CPR. At 5 min following resuscitation, the pigs were randomized and equally assigned into the CCK8 or the control group. CCK8 was continuously infused for 1 h at a dose of 44.4 µg/kg/h and a rate of 20 ml/h in the CCK8 group. Body temperature, hemodynamic measurements and post‑resuscitation myocardial function were monitored in the first 4 h following CPR. Neuron specific enzyme (NSE), S100B protein, tumor necrosis factor (TNF)‑α and interleukin (IL)‑6 were measured at baseline and 4, 12 and 24 h following resuscitation. The neurological deficient score (NDS) was recorded and cerebral samples were collected for terminal deoxynucleotidyl-transferase-mediated dUTP nick end labelling assay and integrated optical density (IOD) analysis at 24 h following CPR. The results revealed that hypothermia was not induced by CCK8; however, post‑resuscitation NSE, S100B, IL‑6 and TNF‑α were significantly decreased, and NDS and IOD were significantly improved in the CCK8 group compared with the control group (P<0.05). The present study revealed that in a porcine model of CPR, CCK8 does not induce hypothermia, but inhibits the inﬂammatory response and significantly improves neurological outcomes.

View Figures

View References

1	Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, et al: Heart disease and stroke statistics-2015 update: A report from the American Heart Association. Circulation. 131:e29–e322. 2015. View Article : Google Scholar : PubMed/NCBI
2	Atwood C, Eisenberg MS, Herlitz J and Rea TD: Incidence of EMS-treated out-of-hospital cardiac arrest in Europe. Resuscitation. 67:75–80. 2005. View Article : Google Scholar : PubMed/NCBI
3	Hua W, Zhang LF, Wu YF, Liu XQ, Guo DS, Zhou HL, Gou ZP, Zhao LC, Niu HX, Chen KP, et al: Incidence of sudden cardiac death in China: Analysis of 4 regional populations. J Am Coll Cardiol. 54:1110–1118. 2009. View Article : Google Scholar : PubMed/NCBI
4	Laver S, Farrow C, Turner D and Nolan J: Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Med. 30:2126–2128. 2004. View Article : Google Scholar : PubMed/NCBI
5	Neumar RW, Shuster M, Callaway CW, Gent LM, Atkins DL, Bhanji F, Brooks SC, de Caen AR, Donnino MW, Ferrer JM, et al: Part 1: executive summary: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 132(18 Suppl 2): S315–S367. 2015. View Article : Google Scholar : PubMed/NCBI
6	Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C, Horn J, Hovdenes J, Kjaergaard J, Kuiper M, et al: Targeted temperature management at 33°C versus 36°C after cardiac arrest. N Engl J Med. 369:2197–2206. 2013. View Article : Google Scholar : PubMed/NCBI
7	Sun S, Tang W, Song F, Chung SP, Weng Y, Yu T and Weil MH: Pharmacologically induced hypothermia with cannabinoid receptor agonist WIN55, 212-2 after cardiopulmonary resuscitation. Crit Care Med. 38:2282–2286. 2010. View Article : Google Scholar : PubMed/NCBI
8	Chung SP, Song FQ, Yu T, Weng Y, Sun S, Weil MH and Tang W: Effect of therapeutic hypothermia vs δ-opioid receptor agonist on post resuscitation myocardial function in a rat model of CPR. Resuscitation. 82:350–354. 2011. View Article : Google Scholar : PubMed/NCBI
9	Weng Y, Sun S, Song F, Phil Chung S, Park J, Harry Weil M and Tang W: Cholecystokinin octapeptide induces hypothermia and improves outcomes in a rat model of cardiopulmonary resuscitation. Crit Care Med. 39:2407–2412. 2011. View Article : Google Scholar : PubMed/NCBI
10	Zetler G: Cholecystokinin octapeptide, caerulein and caerulein analogues: Effects on thermoregulation in the mouse. Neuropharmacology. 21:795–801. 1982. View Article : Google Scholar : PubMed/NCBI
11	Katsuura G and Itoh S: Effect of cholecystokinin octapeptide on body temperature in the rat. Jpn J Physiol. 31:849–858. 1981. View Article : Google Scholar : PubMed/NCBI
12	Tirassa P and Costa N: CCK-8 induces NGF and BDNF synthesis and modulates TrkA and TrkB expression in the rat hippocampus and septum: Effects on kindling development. Neurochem Int. 50:130–138. 2007. View Article : Google Scholar : PubMed/NCBI
13	Zhang JG, Liu JX, Jia XX, Geng J, Yu F and Cong B: Cholecystokinin octapeptide regulates the differentiation and effector cytokine production of CD4(+) T cells in vitro. Int Immunopharmacol. 20:307–315. 2014. View Article : Google Scholar : PubMed/NCBI
14	Ling YL, Huang SS, Wang LF, Zhang JL, Wan M and Hao RL: [Cholecystokinin-octapeptide (CCK-8) reverses experimental endotoxin shock. Sheng Li Xue Bao. 48:390–394. 1996.(In Chinese). PubMed/NCBI
15	Institute for Laboratory Animal Research, . Guide for the Care and Use of Laboratory Animals. 8th. National Research Council; Washington, DC: pp. 1072–1073S. 1996
16	Xu J, Hu X, Yang Z, Wu X, Bisera J, Sun S and Tang W: Miniaturized mechanical chest compressor improves calculated cerebral perfusion pressure without compromising intracranial pressure during cardiopulmonary resuscitation in a porcine model of cardiac arrest. Resuscitation. 85:683–688. 2014. View Article : Google Scholar : PubMed/NCBI
17	Yang Z, Tang D, Wu X, Hu X, Xu J, Qian J, Yang M and Tang W: A tourniquet assisted cardiopulmonary resuscitation augments myocardial perfusion in a porcine model of cardiac arrest. Resuscitation. 86:49–53. 2015. View Article : Google Scholar : PubMed/NCBI
18	Gong P, Li CS, Hua R, Zhao H, Tang ZR, Mei X, Zhang MY and Cui J: Mild hypothermia attenuates mitochondrial oxidative stress by protecting respiratory enzymes and upregulating MnSOD in a pig model of cardiac arrest. PLoS One. 7:e353132012. View Article : Google Scholar : PubMed/NCBI
19	Kapás L, Benedek G and Penke B: Cholecystokinin interferes with the thermoregulatory effect of exogenous and endogenous opioids. Neuropeptides. 14:85–92. 1989. View Article : Google Scholar : PubMed/NCBI
20	Yannopoulos D, Zviman M, Castro V, Kolandaivelu A, Ranjan R, Wilson RF and Halperin HR: Intra-cardiopulmonary resuscitation hypothermia with and without volume loading in an ischemic model of cardiac arrest. Circulation. 120:1426–1435. 2009. View Article : Google Scholar : PubMed/NCBI
21	Ye S, Weng Y, Sun S, Chen W, Wu X, Li Z, Weil MH and Tang W: Comparison of the durations of mild therapeutic hypothermia on outcome after cardiopulmonary resuscitation in the rat. Circulation. 125:123–129. 2012. View Article : Google Scholar : PubMed/NCBI
22	Farkas M and Komáromi I: Central effects of chemical transmitters on temperature regulation in the adult rat and the newborn guinea pig. Int J Biometeorol. 15:316–320. 1971. View Article : Google Scholar : PubMed/NCBI
23	Adrie C, Adib-Conquy M, Laurent I, Monchi M, Vinsonneau C, Fitting C, Fraisse F, Dinh-Xuan AT, Carli P, Spaulding C, et al: Successful cardiopulmonary resuscitation after cardiac arrest as a ‘sepsis-like’ syndrome. Circulation. 106:562–568. 2002. View Article : Google Scholar : PubMed/NCBI
24	Geppert A, Zorn G, Karth GD, Haumer M, Gwechenberger M, Koller-Strametz J, Heinz G, Huber K and Siostrzonek P: Soluble selectins and the systemic inflammatory response syndrome after successful cardiopulmonary resuscitation. Crit Care Med. 28:2360–2365. 2000. View Article : Google Scholar : PubMed/NCBI
25	Miyamoto S, Shikata K, Miyasaka K, Okada S, Sasaki M, Kodera R, Hirota D, Kajitani N, Takatsuka T, Kataoka HU, et al: Cholecystokinin plays a novel protective role in diabetic kidney through anti-inflammatory actions on macrophage: Anti-inflammatory effect of cholecystokinin. Diabetes. 61:897–907. 2012. View Article : Google Scholar : PubMed/NCBI
26	Luyer MD, Greve JW, Hadfoune M, Jacobs JA, Dejong CH and Buurman WA: Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. J Exp Med. 202:1023–1029. 2005. View Article : Google Scholar : PubMed/NCBI
27	McDermott JR, Leslie FC, D'Amato M, Thompson DG, Grencis RK and McLaughlin JT: Immune control of food intake: Enteroendocrine cells are regulated by CD4+ T lymphocytes during small intestinal inflammation. Gut. 55:492–497. 2006. View Article : Google Scholar : PubMed/NCBI
28	Li S, Ni Z, Cong B, Gao W, Xu S, Wang C, Yao Y, Ma C and Ling Y: CCK-8 inhibits LPS-induced IL-1beta production in pulmonary interstitial macrophages by modulating PKA, p38, and NF-kappaB pathway. Shock. 27:678–686. 2007. View Article : Google Scholar : PubMed/NCBI
29	Zhang JG, Cong B, Li QX, Chen HY, Qin J and Fu LH: Cholecystokinin octapeptide regulates lipopolysaccharide-activated B cells co-stimulatory molecule expression and cytokines production in vitro. Immunopharmacol Immunotoxicol. 33:157–163. 2011. View Article : Google Scholar : PubMed/NCBI
30	Zhang JG, Cong B, Jia XX, Li H, Li QX, Ma CL and Feng Y: Cholecystokinin octapeptide inhibits immunoglobulin G1 production of lipopolysaccharide-activated B cells. Int Immunopharmacol. 11:1685–1690. 2011. View Article : Google Scholar : PubMed/NCBI
31	Center for Drug Evaluation and Research (CDER), . Estimating the Maximum Safe. Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy. Volunteers. U.S. Department of Health and Human Services. Food and Drug Administration; Rockville, MD: pp. 6–7S. 2005